Renova holding

studies: J89-024 and J89-025 A double-blind, parallel, U.S. multicenter trial comparing the efficacy and safety of Renova (Tretinoin Emollient Cream) 0.02% with its vehicle qid 24 weeks in the treatment of tactile roughness, fine wrinkling,'coarse wrinkling, mottled hyperpigmentation, yellow-brow. RENOVA tretinoin emollient cream 0.05% is indicated for the treatment of fine wrinkling, mottled hyperpigmentation, and roughness of the skin. These signs are usually associated with photodamaged (sun-damaged) skin and intrinsic aging, but may be associated with other conditions. Renova® Paracetamol BP Description: Paracetamol (Renova®) is a potent and fast acting antipyretic & mild analgesic together with some anti-inflammatory effects. Paracetamol is the most widely used popular domestic analgesic and antipyretic for adults and children with significantly less side effects at the recommended dose. RENOVA (tretinoin emollient cream) 0.05% contains the active ingredient tretinoin (a retinoid) in an emollient cream base. Tretinoin is a yellow to light orange crystalline powder having a characteristic floral odor. Tretinoin, also known as Retin-A and Renova, is a prescription skin medication used to treat many disorders including sun-damaged skin. Many of the signs of skin aging, such as fine wrinkles, are a result of sun exposure. Renova, through its wholly-owned indirect subsidiary Venetos, has acquired a total of 25.51% of shares in S+B through a purchase of 25.29% of shares in S+B from Schmolz + Bickenbach GmbH & Co. KG ('S+B KG') and through a mandatory tender offer required by the Swiss takeover law. RENOVA® (tretinoin cream) 0.02% is indicated as an adjunctive agent (see second bullet point below) for use in the mitigation (palliation) of fine facial wrinkles in patients who use.

Meta: